Emergent Bio readies anthrax vaccine shipments into U.S. stockpile

|About: Emergent BioSolutions ... (EBS)|By:, SA News Editor

The U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) has notified Emergent BioSolutions (NYSE:EBS) that it will begin procuring its AV7909 anthrax vaccine for delivery into the Strategic National Stockpile.

The company says it will deliver the product in H2 under the terms of its contract with BARDA, valued as high as $1.5B.

Subscribe for full text news in your inbox